Infosys has recently taken legal action against Cognizant Technology Solutions in a U.S. district court, according to a report from The Times of India. The Indian tech giant alleges that Cognizant has been abusing its market power to stifle competition and reinforce its leading position in the healthcare software sector through its TriZetto platform.
Allegations of Monopoly Abuse
Infosys claims that the New Jersey-based company has engaged in practices that not only inflate customer costs but also limit competition within the healthcare software market. By intentionally reducing its own output, Cognizant is said to have manipulated the market dynamics to preserve its dominance.
Key Points of the Case
- Cognizant’s TriZetto Platform: Infosys argues that this platform is being used to maintain an unfair competitive edge.
- Customer Overcharging: The allegation includes claims that Cognizant has been overcharging clients, which further exacerbates the competitive imbalance.
- Market Manipulation: Infosys believes that these actions not only harm competitors but also negatively impact consumers, leading to higher prices and fewer options.
This legal battle highlights ongoing tensions in the tech industry, particularly in the healthcare software sector, where competition is crucial for innovation and affordability. As this story unfolds, we will keep you updated on any new developments.
